Inventor · disambiguated record
Chad May
Also filed as: MAY CHAD · MAY CHAD MICHAEL
10 granted patents·10 pending applications·45 citations·filing 1997–2023
87Inventor score
Files withTAKEDA PHARMACEUTICALS CO8PFIZER7SADELAIN MICHEL1SCHEERES DAVID1SLOAN KETTERING INST CANCER1
Top patents by PatentIndex Score
20 records- 0194US11744892B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 5, 2023·2 cites·1 claims
- 0294US11744893B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 5, 2023·2 cites·1 claims
- 0393US11406710B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·8 cites·13 claims
- 0487US11685780B2Single domain antigen binding domains that bind human Trop2TAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 27, 2023·2 cites·20 claims
- 0585US8058061B2Vector encoding human globin gene and use thereof in treatment of hemoglobinopathiesSADELAIN MICHEL·Filed 2009·Granted Nov 15, 2011·4 cites·15 claims
- 0684US7541179B2Vector encoding human globin gene and use thereof in treatment of hemoglobinopathiesSLOAN KETTERING INST CANCER·Filed 2002·Granted Jun 2, 2009·12 cites·24 claims
- 0783US12478673B2Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted Nov 25, 2025·0 cites·21 claims
- 0883US11833216B2Anti-EDB antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Granted Dec 5, 2023·0 cites·25 claims
- 0983US2024261423A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Application pending·0 cites
- 1083US2024181071A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Application pending·0 cites
- 1183US2024156977A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2023·Application pending·0 cites
- 1282US9884921B2Bispecific heterodimeric diabodies and uses thereofPFIZER·Filed 2015·Granted Feb 6, 2018·4 cites·34 claims
- 1371US2024199739A1Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1466US2019269791A1Anti-edb antibodies and antibody-drug conjugatesPFIZER·Filed 2017·Application pending·0 cites
- 1558US2024199744A1Therapeutic methods using constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 1657US2023340159A1Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICAL COMPAMY LTD·Filed 2023·Application pending·0 cites
- 1755US2014308161A1System and method for volumetric reduction of medical textile and waste materialSCHEERES DAVID·Filed 2014·Application pending·0 cites
- 1852US2024026011A1Constrained conditionally activated binding proteinsTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1947US2018155452A1Bispecific heterodimeric diabodies and uses thereofPFIZER·Filed 2017·Application pending·0 cites
- 2042US6485722B1Method for selective engraftment of drug-resistant hematopoietic stem cellsUNIV MINNESOTA·Filed 1997·Granted Nov 26, 2002·11 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Chad May files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →